Concepedia

Birgit Haier

BH

8

Publications

683

Citations

8

H-Index

1996

Active since

Affiliations

UCB Pharma (Germany)(Current)

University of Cologne

UCB Pharma (United Kingdom)

Biogen (Switzerland)

UCB Pharma (United States)

Birgit Haier is an author at UCB Pharma (Germany) specializing in immune regulation, medicine, and immunology.

Top concepts

Publications per year

1996–2021

8

Publications

8

STAT3 is constitutively activated in Hodgkin cell lines

Dieter Kube, Udo Holtick, Martina Vockerodt et al. · Blood · 2001 · 215 citations · Full text

First‐in‐human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL‐17A and IL‐17F, in mild psoriasis

Sophie Glatt, Eric Helmer, Birgit Haier et al. · British Journal of Clinical Pharmacology · 2016 · 140 citations · Full text

Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus

Richard Furie, Ian N Bruce, Thomas Dörner et al. · Lara D. Veeken · 2021 · 107 citations · Full text

The Epstein–Barr Virus Latent Membrane Protein 1 Induces Interleukin-10 in Burkitt's Lymphoma Cells but Not in Hodgkin's Cells Involving the p38/SAPK2 Pathway

Martina Vockerodt, Birgit Haier, Peter Buttgereit et al. · Virology · 2001 · 85 citations

, , +16

Expression of Epstein-Barr Virus Nuclear Antigen 1 Is Associated with Enhanced Expression of CD25 in the Hodgkin Cell Line L428

Dieter Kube, Martina Vockerodt, Olaf Weber et al. · Journal of Virology · 1999 · 74 citations · Full text

Rows per page

1–5 of 8